港股医药股显著反弹 药明生物(02269.HK)涨超6%
Mei Ri Jing Ji Xin Wen·2025-12-19 03:16

Group 1 - Hong Kong pharmaceutical stocks showed a significant rebound this morning, particularly in the CRO and innovative drug sectors [1] - Kelaiying (06821.HK) increased by 6.28%, reaching HKD 77 [1] - WuXi Biologics (02269.HK) rose by 6.11%, trading at HKD 34.72 [1] - Sangfor Pharmaceuticals (01530.HK) gained 5.04%, priced at HKD 26.68 [1] - Innovent Biologics (09969.HK) saw an increase of 4.25%, with shares at HKD 13.74 [1]